Deutsche Bank’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Deutsche Bank’s Portfolio DOVA Stock Details DOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-28,662	Closed	-$800K	–	5267
2019 Q3	$800K	Buy	28,662 +25,089	+702%	+$406K	﹤0.01%	2433
2019 Q2	$48K	Sell	3,573 -9,344	-72%	-$88.9K	﹤0.01%	4530
2019 Q1	$113K	Buy	12,917 +372	+3%	+$3.02K	﹤0.01%	4258
2018 Q4	$94K	Sell	12,545 -18,184	-59%	-$293K	﹤0.01%	4248
2018 Q3	$645K	Sell	30,729 -263	-0.8%	-$6.26K	﹤0.01%	3617
2018 Q2	$928K	Buy	30,992 +19,053	+160%	+$519K	﹤0.01%	3482
2018 Q1	$322K	Buy	11,939 +191	+2%	+$5.71K	﹤0.01%	3954
2017 Q4	$337K	Buy	11,748 +6,836	+139%	+$187K	﹤0.01%	3795
2017 Q3	$118K	Buy	+4,912	New	+$116K	﹤0.01%	4112

Deutsche Bank's DOVA Position: Q4 2019 in Review

Deutsche Bank sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 28,662 shares — an estimated $800K sold.

Deutsche Bank first reported a position in DOVA in Q3 2017 and held it in 9 quarters. The position peaked at $928K in Q2 2018. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

Deutsche Bank reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Deutsche Bank sold 28,662 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $800K.
Deutsche Bank first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 9 quarters.
Deutsche Bank's Dova Pharmaceuticals, Inc. Common Stock position peaked at $928K in Q2 2018.
0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Deutsche Bank's 13F filing for Q4 2019, filed 14 Feb 2020.